ACADIA Pharmaceuticals, Inc. (ACAD)
23.99
-0.34
(-1.40%)
USD |
NASDAQ |
Feb 20, 16:00
24.40
+0.41
(+1.71%)
After-Hours: 20:00
ACADIA Pharmaceuticals Market Cap : 4.059B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 24.18M |
| Dynavax Technologies Corp. (DELISTED) | 1.820B |
| Axsome Therapeutics, Inc. | 9.262B |
| Rhythm Pharmaceuticals, Inc. | 6.659B |
| Alnylam Pharmaceuticals, Inc. | 44.59B |
Market Cap Related Metrics
| PE Ratio | 15.44 |
| PS Ratio | 3.859 |
| PEG Ratio | 0.1525 |
| Price to Book Value | 4.425 |
| Price to Free Cash Flow | 40.82 |
| Price | 23.99 |
| Earnings Yield | 6.48% |
| PEGY Ratio | 0.1525 |
| Operating PE Ratio | 42.80 |
| Normalized PE Ratio | 15.44 |